RESONANCE logo

Resonance Specialities Ltd

RESONANCE·BSE·
₹189.10▼ -9.20 (-4.64%)
Market Cap219.28 Cr
PE Ratio20.99
Volume21,589
Day High - Low208.80 - 187.00
52W High-Low209.95 - 77.00

Resonance Specialities Ltd (RESONANCE): company summary

The company's business is improving, with annual revenue rising 16.0% and net profit growing 58.3%.

Resonance Specialities Ltd (RESONANCE) is a micro-cap Chemicals company valued at ₹219 crore operating in Specialty Chemicals on the NSE and BSE.

Recent price move
Resonance Specialities Ltd last traded at ₹189.1, down 4.64% on the day.
Recent developments
2026-09-30: Promoter holding remained at 54.25%, indicating no significant change in ownership. 2026-06-30: The company reported a sharp rise in both revenue and net profit for the latest quarter, reflecting improved performance. 2026-03-31: The company's financials showed continued growth, with revenue and net profit rising compared to the prior quarter.
Financial performance
The company's business is improving, with annual revenue rising 16.0% and net profit growing 58.3%. The latest quarter saw revenue jump 53.2% and net profit surge 252.1% compared to the same quarter a year earlier, driven by stronger margins that widened 3.1 percentage points to 11.5%.
Valuation multiples
The stock trades at 21.0 times earnings, 2.84 times book value. It yields 0.6%.
Things to watch
The stock is 5.5% below its 52-week high, which may indicate a pullback from recent peak levels. While the company remains almost debt-free, the recent surge in net profit may not be sustainable if market conditions change. The 5-year profit growth has been negative, suggesting potential challenges in maintaining past performance.
Where it stands
Resonance Specialities Ltd has shown strong growth in both revenue and net profit, with the latest quarter marking a significant increase. The company's net profit margin has improved, and its return on equity remains at 14.2%. The stock is currently 5.5% below its 52-week high, but the company's financials remain solid with low debt.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
4.8/10
Weak
Fair Value
Sign in to see
ROE
14.19%
Average
P/E
20.99x
Fair
Debt / Equity
0.03
Low
Industry
Chemicals
Specialty Chemicals
Overall View
Mixed

Price performance

Day₹187.00
₹208.80
52W₹77.00
₹209.95
DocStoX take

Supported by momentum (7.5) and risk (6.7), but held back by growth (1.6). Momentum looks strong at 7.5, but that is offset by growth at 1.6. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.8
/10
Weak
Quality
Solid
ROE 14.2%
Valuation
Rich
P/E 21.0×
Growth
Flat
Revenue +5.2% 5Y CAGR
Risk
Moderate
D/E 0.03
Momentum
Strong
84% of 52-week range

At a glance

Market Cap
₹219 Cr
52W High / Low
₹210 / ₹77
Dividend Yield
0.58%
Promoter Holding
54.25%
EPS (TTM)
₹9.01
Book Value
₹63.44

Key highlights

  • Low leverage — D/E 0.03
  • Profitable in all of the last 5 years
  • Profit shrinking 1% a year
  • Growth is weak (1.6/10)
2 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Chemicals stocks · Specialty Chemicals

Resonance Specialities Ltd peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.